Detalles de la búsqueda
1.
Factors associated with sick leave duration in patients suffering from major depressive disorder initiating antidepressant treatment: a real-world evidence study in Germany and Spain.
Int J Psychiatry Clin Pract
; 27(1): 59-68, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35801359
2.
Predictors of sick leave days in patients affected by major depressive disorder receiving antidepressant treatment in general practice setting in Germany.
Int J Psychiatry Clin Pract
; 25(4): 393-402, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34543170
3.
Estimation of brain receptor occupancy for trazodone immediate release and once a day formulations.
Clin Transl Sci
; 15(6): 1417-1429, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35233913
4.
Management and Treatment of Patients With Major Depressive Disorder and Chronic Diseases: A Multidisciplinary Approach.
Front Psychol
; 11: 542444, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33101117
5.
A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorder.
Int Clin Psychopharmacol
; 35(3): 137-146, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31972628
Resultados
1 -
5
de 5
1
Próxima >
>>